Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDT NASDAQ:GH NASDAQ:OPCH NASDAQ:RDNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$12.85+1.3%$12.28$10.10▼$20.72$1.81B0.3266,205 shs372,435 shsGHGuardant Health$55.40+1.1%$54.00$20.14▼$68.00$6.83B1.462.23 million shs2.16 million shsOPCHOption Care Health$27.56-1.2%$28.96$21.39▼$35.53$4.53B0.821.80 million shs2.01 million shsRDNTRadNet$74.36-0.8%$63.82$45.00▼$93.65$5.77B1.54596,571 shs1.20 million shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health-3.25%-6.00%+1.32%-0.53%-30.33%GHGuardant Health-0.20%-8.94%-6.95%+10.62%+104.52%OPCHOption Care Health-2.07%-5.75%-1.52%-12.41%-12.82%RDNTRadNet+1.32%+4.17%+11.18%+32.58%+10.62%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health$12.85+1.3%$12.28$10.10▼$20.72$1.81B0.3266,205 shs372,435 shsGHGuardant Health$55.40+1.1%$54.00$20.14▼$68.00$6.83B1.462.23 million shs2.16 million shsOPCHOption Care Health$27.56-1.2%$28.96$21.39▼$35.53$4.53B0.821.80 million shs2.01 million shsRDNTRadNet$74.36-0.8%$63.82$45.00▼$93.65$5.77B1.54596,571 shs1.20 million shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health-3.25%-6.00%+1.32%-0.53%-30.33%GHGuardant Health-0.20%-8.94%-6.95%+10.62%+104.52%OPCHOption Care Health-2.07%-5.75%-1.52%-12.41%-12.82%RDNTRadNet+1.32%+4.17%+11.18%+32.58%+10.62%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health 2.73Moderate Buy$19.3350.41% UpsideGHGuardant Health 3.06Buy$58.245.12% UpsideOPCHOption Care Health 2.89Moderate Buy$35.7529.72% UpsideRDNTRadNet 3.25Buy$76.803.28% UpsideCurrent Analyst Ratings BreakdownLatest ARDT, GH, RDNT, and OPCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/10/2025ARDTArdent HealthUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$17.009/4/2025GHGuardant HealthBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $70.009/3/2025RDNTRadNetBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$60.00 ➝ $79.009/3/2025RDNTRadNetTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$74.00 ➝ $81.008/18/2025RDNTRadNetZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/13/2025RDNTRadNetRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingStrong-Buy$66.00 ➝ $75.008/11/2025RDNTRadNetMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeOverweight8/11/2025ARDTArdent HealthJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$18.00 ➝ $15.008/7/2025ARDTArdent HealthKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$24.00 ➝ $20.007/31/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$36.00 ➝ $38.007/31/2025OPCHOption Care HealthCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health$5.97B0.31$2.49 per share5.16$10.66 per share1.21GHGuardant Health$828.85M8.34N/AN/A($1.13) per share-49.03OPCHOption Care Health$5.37B0.83$1.59 per share17.31$8.25 per share3.34RDNTRadNet$1.83B3.13$3.50 per share21.25$15.31 per share4.86Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health$210.34M$1.817.106.565.784.11%16.66%5.18%11/5/2025 (Estimated)GHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%11/5/2025 (Estimated)OPCHOption Care Health$211.82M$1.2522.0521.871.733.93%17.53%7.17%10/29/2025 (Estimated)RDNTRadNet$2.79M-$0.20N/A140.30N/A-0.78%2.41%0.82%11/10/2025 (Estimated)Latest ARDT, GH, RDNT, and OPCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/10/2025Q2 2025RDNTRadNet$0.17$0.31+$0.14$0.43$488.06 million$498.23 million8/5/2025Q2 2025ARDTArdent Health$0.30$0.52+$0.22$0.52$1.54 billion$1.65 billion7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 million7/30/2025Q2 2025OPCHOption Care Health$0.40$0.41+$0.01$0.31$1.35 billion$1.42 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent HealthN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health0.662.132.00GHGuardant HealthN/A3.713.35OPCHOption Care Health0.811.521.00RDNTRadNet0.912.002.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent HealthN/AGHGuardant Health92.60%OPCHOption Care Health98.05%RDNTRadNet77.90%Insider OwnershipCompanyInsider OwnershipARDTArdent Health1.70%GHGuardant Health6.10%OPCHOption Care Health0.64%RDNTRadNet5.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health24,900143.11 million140.67 millionOptionableGHGuardant Health2,021124.71 million117.10 millionNot OptionableOPCHOption Care Health8,088162.30 million161.26 millionOptionableRDNTRadNet11,02176.92 million72.61 millionOptionableARDT, GH, RDNT, and OPCH HeadlinesRecent News About These CompaniesRadNet (NASDAQ:RDNT) CEO Cornelis Wesdorp Sells 500 SharesSeptember 16 at 8:18 AM | marketbeat.comCornelis Wesdorp Sells 500 Shares of RadNet (NASDAQ:RDNT) StockSeptember 16 at 5:10 AM | insidertrades.comIntech Investment Management LLC Acquires 22,198 Shares of RadNet, Inc. $RDNTSeptember 15 at 3:19 AM | marketbeat.comInsider Selling: RadNet (NASDAQ:RDNT) COO Sells 10,000 Shares of StockSeptember 14 at 5:32 PM | marketbeat.comNorman Hames Sells 10,000 Shares of RadNet (NASDAQ:RDNT) StockSeptember 13 at 6:38 AM | insidertrades.comInsider Selling: RadNet (NASDAQ:RDNT) CEO Sells 500 Shares of StockSeptember 11, 2025 | insidertrades.comFred Alger Management LLC Raises Holdings in RadNet, Inc. $RDNTSeptember 11, 2025 | marketbeat.comAxiom Investors LLC DE Trims Stake in RadNet, Inc. $RDNTSeptember 10, 2025 | marketbeat.comRadNet, Inc. (RDNT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comRoyal Bank of Canada Increases Stake in RadNet, Inc. $RDNTSeptember 10, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 27,655 Shares of RadNet, Inc. $RDNTSeptember 9, 2025 | marketbeat.comRadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025September 8, 2025 | globenewswire.comPunch & Associates Investment Management Inc. Raises Holdings in RadNet, Inc. $RDNTSeptember 8, 2025 | marketbeat.comAlyeska Investment Group L.P. Acquires 712,270 Shares of RadNet, Inc. $RDNTSeptember 6, 2025 | marketbeat.comRadNet (NASDAQ:RDNT) Price Target Raised to $81.00September 6, 2025 | americanbankingnews.comBarclays Raises RadNet (NASDAQ:RDNT) Price Target to $79.00September 5, 2025 | marketbeat.comTruist Financial Forecasts Strong Price Appreciation for RadNet (NASDAQ:RDNT) StockSeptember 5, 2025 | marketbeat.com1 High-Flying Stock for Long-Term Investors and 2 We AvoidSeptember 4, 2025 | finance.yahoo.comRadNet price target raised to $81 from $74 at TruistSeptember 3, 2025 | msn.comRadNet price target raised to $79 from $60 at BarclaysSeptember 3, 2025 | msn.comRadNet, Inc. $RDNT Shares Acquired by Beck Mack & Oliver LLCSeptember 2, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 High Short-Interest Stocks to Buy Before NovemberBy Thomas Hughes | August 20, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025Amazon Stock Sets Up for Breakout After Bullish CrossoverBy Sam Quirke | August 21, 2025Take Profits Now: 3 Overbought Stocks Primed for a PullbackBy Dan Schmidt | August 25, 2025NVIDIA Stock Could Pull Back in September, But Don’t Bet on ItBy Thomas Hughes | August 28, 2025ARDT, GH, RDNT, and OPCH Company DescriptionsArdent Health NYSE:ARDT$12.85 +0.17 (+1.34%) Closing price 03:59 PM EasternExtended Trading$12.86 +0.01 (+0.08%) As of 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Guardant Health NASDAQ:GH$55.40 +0.61 (+1.11%) Closing price 04:00 PM EasternExtended Trading$55.72 +0.32 (+0.57%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Option Care Health NASDAQ:OPCH$27.56 -0.33 (-1.18%) Closing price 04:00 PM EasternExtended Trading$27.62 +0.07 (+0.24%) As of 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.RadNet NASDAQ:RDNT$74.36 -0.63 (-0.84%) Closing price 04:00 PM EasternExtended Trading$74.06 -0.30 (-0.40%) As of 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Resideo Technologies: Institutional Activity Signals 30% Upside Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Palantir’s Commercial Growth Story Is Just Getting Started How Bath & Body Works Is a Perfect Example of a Value Stock The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Uranium Energy Stock Has Momentum—and More Upside Ahead Why Opendoor Stock Is Soaring—and May Just Be Starting Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
